0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Non-sterile Liquid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-28W13982
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non sterile Liquid Market Research Report 2023
BUY CHAPTERS

Non-sterile Liquid - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28W13982
Report
October 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-sterile Liquid - Market Size

The global market for Non-sterile Liquid was estimated to be worth US$ 2600 million in 2023 and is forecast to a readjusted size of US$ 3900.9 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030

Non-sterile Liquid - Market

Non-sterile Liquid - Market

Non-sterile liquid can be used to deliver a variety of medications, including prescription drugs, non-prescription drugs, vitamins, dietary supplements, and nutraceuticals.
North American market for Non-sterile Liquid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-sterile Liquid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Non-sterile Liquid was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Non-sterile Liquid include Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences and Bora Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-sterile Liquid, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-sterile Liquid by region & country, by Type, and by Application.
The Non-sterile Liquid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-sterile Liquid.
Market Segmentation

Scope of Non-sterile Liquid - Market Report

Report Metric Details
Report Name Non-sterile Liquid - Market
Forecasted market size in 2030 US$ 3900.9 million
CAGR 6.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Solution
  • Suspension
  • Gel
  • Syrup
  • Ethanolic Liquid
Segment by Application
  • Human Medication
  • Nutraceuticals
  • Cosmetics
  • Medical Devices
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals, Cambrex Corporation, JGL d.d., Mikart, PharmaVision, Pierre Fabre, TriRx Pharmaceutical Services, UI Pharmaceuticals, Wasdell Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Non-sterile Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Non-sterile Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Non-sterile Liquid in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Non-sterile Liquid - Market size in 2030?

Ans: The Non-sterile Liquid - Market size in 2030 will be US$ 3900.9 million.

Who are the main players in the Non-sterile Liquid - Market report?

Ans: The main players in the Non-sterile Liquid - Market are Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences, Bora Pharmaceuticals, Cambrex Corporation, JGL d.d., Mikart, PharmaVision, Pierre Fabre, TriRx Pharmaceutical Services, UI Pharmaceuticals, Wasdell Group

What are the Application segmentation covered in the Non-sterile Liquid - Market report?

Ans: The Applications covered in the Non-sterile Liquid - Market report are Human Medication, Nutraceuticals, Cosmetics, Medical Devices

What are the Type segmentation covered in the Non-sterile Liquid - Market report?

Ans: The Types covered in the Non-sterile Liquid - Market report are Solution, Suspension, Gel, Syrup, Ethanolic Liquid

1 Market Overview
1.1 Non-sterile Liquid Product Introduction
1.2 Global Non-sterile Liquid Market Size Forecast
1.2.1 Global Non-sterile Liquid Sales Value (2019-2030)
1.2.2 Global Non-sterile Liquid Sales Volume (2019-2030)
1.2.3 Global Non-sterile Liquid Sales Price (2019-2030)
1.3 Non-sterile Liquid Market Trends & Drivers
1.3.1 Non-sterile Liquid Industry Trends
1.3.2 Non-sterile Liquid Market Drivers & Opportunity
1.3.3 Non-sterile Liquid Market Challenges
1.3.4 Non-sterile Liquid Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-sterile Liquid Players Revenue Ranking (2023)
2.2 Global Non-sterile Liquid Revenue by Company (2019-2024)
2.3 Global Non-sterile Liquid Players Sales Volume Ranking (2023)
2.4 Global Non-sterile Liquid Sales Volume by Company Players (2019-2024)
2.5 Global Non-sterile Liquid Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-sterile Liquid Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-sterile Liquid Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-sterile Liquid
2.9 Non-sterile Liquid Market Competitive Analysis
2.9.1 Non-sterile Liquid Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-sterile Liquid Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-sterile Liquid as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Solution
3.1.2 Suspension
3.1.3 Gel
3.1.4 Syrup
3.1.5 Ethanolic Liquid
3.2 Global Non-sterile Liquid Sales Value by Type
3.2.1 Global Non-sterile Liquid Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-sterile Liquid Sales Value, by Type (2019-2030)
3.2.3 Global Non-sterile Liquid Sales Value, by Type (%) (2019-2030)
3.3 Global Non-sterile Liquid Sales Volume by Type
3.3.1 Global Non-sterile Liquid Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-sterile Liquid Sales Volume, by Type (2019-2030)
3.3.3 Global Non-sterile Liquid Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-sterile Liquid Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human Medication
4.1.2 Nutraceuticals
4.1.3 Cosmetics
4.1.4 Medical Devices
4.2 Global Non-sterile Liquid Sales Value by Application
4.2.1 Global Non-sterile Liquid Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-sterile Liquid Sales Value, by Application (2019-2030)
4.2.3 Global Non-sterile Liquid Sales Value, by Application (%) (2019-2030)
4.3 Global Non-sterile Liquid Sales Volume by Application
4.3.1 Global Non-sterile Liquid Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-sterile Liquid Sales Volume, by Application (2019-2030)
4.3.3 Global Non-sterile Liquid Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-sterile Liquid Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-sterile Liquid Sales Value by Region
5.1.1 Global Non-sterile Liquid Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-sterile Liquid Sales Value by Region (2019-2024)
5.1.3 Global Non-sterile Liquid Sales Value by Region (2025-2030)
5.1.4 Global Non-sterile Liquid Sales Value by Region (%), (2019-2030)
5.2 Global Non-sterile Liquid Sales Volume by Region
5.2.1 Global Non-sterile Liquid Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-sterile Liquid Sales Volume by Region (2019-2024)
5.2.3 Global Non-sterile Liquid Sales Volume by Region (2025-2030)
5.2.4 Global Non-sterile Liquid Sales Volume by Region (%), (2019-2030)
5.3 Global Non-sterile Liquid Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-sterile Liquid Sales Value, 2019-2030
5.4.2 North America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-sterile Liquid Sales Value, 2019-2030
5.5.2 Europe Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-sterile Liquid Sales Value, 2019-2030
5.6.2 Asia Pacific Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-sterile Liquid Sales Value, 2019-2030
5.7.2 South America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-sterile Liquid Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-sterile Liquid Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-sterile Liquid Sales Value
6.2.1 Key Countries/Regions Non-sterile Liquid Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-sterile Liquid Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-sterile Liquid Sales Value, 2019-2030
6.3.2 United States Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-sterile Liquid Sales Value, 2019-2030
6.4.2 Europe Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-sterile Liquid Sales Value, 2019-2030
6.5.2 China Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-sterile Liquid Sales Value, 2019-2030
6.6.2 Japan Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-sterile Liquid Sales Value, 2019-2030
6.7.2 South Korea Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-sterile Liquid Sales Value, 2019-2030
6.8.2 Southeast Asia Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-sterile Liquid Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-sterile Liquid Sales Value, 2019-2030
6.9.2 India Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-sterile Liquid Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Nycomed
7.1.1 Nycomed Company Information
7.1.2 Nycomed Introduction and Business Overview
7.1.3 Nycomed Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Nycomed Non-sterile Liquid Product Offerings
7.1.5 Nycomed Recent Development
7.2 AbbVie
7.2.1 AbbVie Company Information
7.2.2 AbbVie Introduction and Business Overview
7.2.3 AbbVie Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AbbVie Non-sterile Liquid Product Offerings
7.2.5 AbbVie Recent Development
7.3 Aenova
7.3.1 Aenova Company Information
7.3.2 Aenova Introduction and Business Overview
7.3.3 Aenova Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Aenova Non-sterile Liquid Product Offerings
7.3.5 Aenova Recent Development
7.4 APPCO
7.4.1 APPCO Company Information
7.4.2 APPCO Introduction and Business Overview
7.4.3 APPCO Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.4.4 APPCO Non-sterile Liquid Product Offerings
7.4.5 APPCO Recent Development
7.5 Atral Pharmaceutical
7.5.1 Atral Pharmaceutical Company Information
7.5.2 Atral Pharmaceutical Introduction and Business Overview
7.5.3 Atral Pharmaceutical Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Atral Pharmaceutical Non-sterile Liquid Product Offerings
7.5.5 Atral Pharmaceutical Recent Development
7.6 Aurigene Pharmaceutical Services
7.6.1 Aurigene Pharmaceutical Services Company Information
7.6.2 Aurigene Pharmaceutical Services Introduction and Business Overview
7.6.3 Aurigene Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Aurigene Pharmaceutical Services Non-sterile Liquid Product Offerings
7.6.5 Aurigene Pharmaceutical Services Recent Development
7.7 Biological E. Ltd.
7.7.1 Biological E. Ltd. Company Information
7.7.2 Biological E. Ltd. Introduction and Business Overview
7.7.3 Biological E. Ltd. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biological E. Ltd. Non-sterile Liquid Product Offerings
7.7.5 Biological E. Ltd. Recent Development
7.8 BioPlus Life Sciences
7.8.1 BioPlus Life Sciences Company Information
7.8.2 BioPlus Life Sciences Introduction and Business Overview
7.8.3 BioPlus Life Sciences Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.8.4 BioPlus Life Sciences Non-sterile Liquid Product Offerings
7.8.5 BioPlus Life Sciences Recent Development
7.9 Bora Pharmaceuticals
7.9.1 Bora Pharmaceuticals Company Information
7.9.2 Bora Pharmaceuticals Introduction and Business Overview
7.9.3 Bora Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bora Pharmaceuticals Non-sterile Liquid Product Offerings
7.9.5 Bora Pharmaceuticals Recent Development
7.10 Cambrex Corporation
7.10.1 Cambrex Corporation Company Information
7.10.2 Cambrex Corporation Introduction and Business Overview
7.10.3 Cambrex Corporation Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Cambrex Corporation Non-sterile Liquid Product Offerings
7.10.5 Cambrex Corporation Recent Development
7.11 JGL d.d.
7.11.1 JGL d.d. Company Information
7.11.2 JGL d.d. Introduction and Business Overview
7.11.3 JGL d.d. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.11.4 JGL d.d. Non-sterile Liquid Product Offerings
7.11.5 JGL d.d. Recent Development
7.12 Mikart
7.12.1 Mikart Company Information
7.12.2 Mikart Introduction and Business Overview
7.12.3 Mikart Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Mikart Non-sterile Liquid Product Offerings
7.12.5 Mikart Recent Development
7.13 PharmaVision
7.13.1 PharmaVision Company Information
7.13.2 PharmaVision Introduction and Business Overview
7.13.3 PharmaVision Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.13.4 PharmaVision Non-sterile Liquid Product Offerings
7.13.5 PharmaVision Recent Development
7.14 Pierre Fabre
7.14.1 Pierre Fabre Company Information
7.14.2 Pierre Fabre Introduction and Business Overview
7.14.3 Pierre Fabre Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Pierre Fabre Non-sterile Liquid Product Offerings
7.14.5 Pierre Fabre Recent Development
7.15 TriRx Pharmaceutical Services
7.15.1 TriRx Pharmaceutical Services Company Information
7.15.2 TriRx Pharmaceutical Services Introduction and Business Overview
7.15.3 TriRx Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.15.4 TriRx Pharmaceutical Services Non-sterile Liquid Product Offerings
7.15.5 TriRx Pharmaceutical Services Recent Development
7.16 UI Pharmaceuticals
7.16.1 UI Pharmaceuticals Company Information
7.16.2 UI Pharmaceuticals Introduction and Business Overview
7.16.3 UI Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.16.4 UI Pharmaceuticals Non-sterile Liquid Product Offerings
7.16.5 UI Pharmaceuticals Recent Development
7.17 Wasdell Group
7.17.1 Wasdell Group Company Information
7.17.2 Wasdell Group Introduction and Business Overview
7.17.3 Wasdell Group Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Wasdell Group Non-sterile Liquid Product Offerings
7.17.5 Wasdell Group Recent Development
8 Industry Chain Analysis
8.1 Non-sterile Liquid Industrial Chain
8.2 Non-sterile Liquid Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-sterile Liquid Sales Model
8.5.2 Sales Channel
8.5.3 Non-sterile Liquid Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Non-sterile Liquid Market Trends
    Table 2. Non-sterile Liquid Market Drivers & Opportunity
    Table 3. Non-sterile Liquid Market Challenges
    Table 4. Non-sterile Liquid Market Restraints
    Table 5. Global Non-sterile Liquid Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Non-sterile Liquid Revenue Market Share by Company (2019-2024)
    Table 7. Global Non-sterile Liquid Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Non-sterile Liquid Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Non-sterile Liquid Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Non-sterile Liquid Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Non-sterile Liquid Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Non-sterile Liquid
    Table 13. Global Non-sterile Liquid Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-sterile Liquid as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Non-sterile Liquid Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Non-sterile Liquid Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Non-sterile Liquid Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Non-sterile Liquid Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Non-sterile Liquid Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Non-sterile Liquid Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Non-sterile Liquid Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Non-sterile Liquid Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Non-sterile Liquid Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Non-sterile Liquid Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Non-sterile Liquid Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Non-sterile Liquid Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Non-sterile Liquid Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Non-sterile Liquid Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Non-sterile Liquid Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Non-sterile Liquid Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Non-sterile Liquid Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Non-sterile Liquid Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Non-sterile Liquid Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Non-sterile Liquid Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Non-sterile Liquid Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Non-sterile Liquid Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Non-sterile Liquid Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Non-sterile Liquid Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Non-sterile Liquid Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Non-sterile Liquid Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Non-sterile Liquid Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Non-sterile Liquid Sales Value by Region (2019-2024) & (%)
    Table 44. Global Non-sterile Liquid Sales Value by Region (2025-2030) & (%)
    Table 45. Global Non-sterile Liquid Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Non-sterile Liquid Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Non-sterile Liquid Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Non-sterile Liquid Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Non-sterile Liquid Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Non-sterile Liquid Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Non-sterile Liquid Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Non-sterile Liquid Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Non-sterile Liquid Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Non-sterile Liquid Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Non-sterile Liquid Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Non-sterile Liquid Sales Volume, (2025-2030) & (K Units)
    Table 57. Nycomed Company Information
    Table 58. Nycomed Introduction and Business Overview
    Table 59. Nycomed Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Nycomed Non-sterile Liquid Product Offerings
    Table 61. Nycomed Recent Development
    Table 62. AbbVie Company Information
    Table 63. AbbVie Introduction and Business Overview
    Table 64. AbbVie Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. AbbVie Non-sterile Liquid Product Offerings
    Table 66. AbbVie Recent Development
    Table 67. Aenova Company Information
    Table 68. Aenova Introduction and Business Overview
    Table 69. Aenova Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Aenova Non-sterile Liquid Product Offerings
    Table 71. Aenova Recent Development
    Table 72. APPCO Company Information
    Table 73. APPCO Introduction and Business Overview
    Table 74. APPCO Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. APPCO Non-sterile Liquid Product Offerings
    Table 76. APPCO Recent Development
    Table 77. Atral Pharmaceutical Company Information
    Table 78. Atral Pharmaceutical Introduction and Business Overview
    Table 79. Atral Pharmaceutical Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Atral Pharmaceutical Non-sterile Liquid Product Offerings
    Table 81. Atral Pharmaceutical Recent Development
    Table 82. Aurigene Pharmaceutical Services Company Information
    Table 83. Aurigene Pharmaceutical Services Introduction and Business Overview
    Table 84. Aurigene Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Aurigene Pharmaceutical Services Non-sterile Liquid Product Offerings
    Table 86. Aurigene Pharmaceutical Services Recent Development
    Table 87. Biological E. Ltd. Company Information
    Table 88. Biological E. Ltd. Introduction and Business Overview
    Table 89. Biological E. Ltd. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Biological E. Ltd. Non-sterile Liquid Product Offerings
    Table 91. Biological E. Ltd. Recent Development
    Table 92. BioPlus Life Sciences Company Information
    Table 93. BioPlus Life Sciences Introduction and Business Overview
    Table 94. BioPlus Life Sciences Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. BioPlus Life Sciences Non-sterile Liquid Product Offerings
    Table 96. BioPlus Life Sciences Recent Development
    Table 97. Bora Pharmaceuticals Company Information
    Table 98. Bora Pharmaceuticals Introduction and Business Overview
    Table 99. Bora Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Bora Pharmaceuticals Non-sterile Liquid Product Offerings
    Table 101. Bora Pharmaceuticals Recent Development
    Table 102. Cambrex Corporation Company Information
    Table 103. Cambrex Corporation Introduction and Business Overview
    Table 104. Cambrex Corporation Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Cambrex Corporation Non-sterile Liquid Product Offerings
    Table 106. Cambrex Corporation Recent Development
    Table 107. JGL d.d. Company Information
    Table 108. JGL d.d. Introduction and Business Overview
    Table 109. JGL d.d. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. JGL d.d. Non-sterile Liquid Product Offerings
    Table 111. JGL d.d. Recent Development
    Table 112. Mikart Company Information
    Table 113. Mikart Introduction and Business Overview
    Table 114. Mikart Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Mikart Non-sterile Liquid Product Offerings
    Table 116. Mikart Recent Development
    Table 117. PharmaVision Company Information
    Table 118. PharmaVision Introduction and Business Overview
    Table 119. PharmaVision Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. PharmaVision Non-sterile Liquid Product Offerings
    Table 121. PharmaVision Recent Development
    Table 122. Pierre Fabre Company Information
    Table 123. Pierre Fabre Introduction and Business Overview
    Table 124. Pierre Fabre Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Pierre Fabre Non-sterile Liquid Product Offerings
    Table 126. Pierre Fabre Recent Development
    Table 127. TriRx Pharmaceutical Services Company Information
    Table 128. TriRx Pharmaceutical Services Introduction and Business Overview
    Table 129. TriRx Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. TriRx Pharmaceutical Services Non-sterile Liquid Product Offerings
    Table 131. TriRx Pharmaceutical Services Recent Development
    Table 132. UI Pharmaceuticals Company Information
    Table 133. UI Pharmaceuticals Introduction and Business Overview
    Table 134. UI Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. UI Pharmaceuticals Non-sterile Liquid Product Offerings
    Table 136. UI Pharmaceuticals Recent Development
    Table 137. Wasdell Group Company Information
    Table 138. Wasdell Group Introduction and Business Overview
    Table 139. Wasdell Group Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Wasdell Group Non-sterile Liquid Product Offerings
    Table 141. Wasdell Group Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Non-sterile Liquid Downstream Customers
    Table 145. Non-sterile Liquid Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-sterile Liquid Product Picture
    Figure 2. Global Non-sterile Liquid Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Non-sterile Liquid Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Non-sterile Liquid Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Non-sterile Liquid Report Years Considered
    Figure 7. Global Non-sterile Liquid Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Non-sterile Liquid Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-sterile Liquid Revenue in 2023
    Figure 10. Non-sterile Liquid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Solution Picture
    Figure 12. Suspension Picture
    Figure 13. Gel Picture
    Figure 14. Syrup Picture
    Figure 15. Ethanolic Liquid Picture
    Figure 16. Global Non-sterile Liquid Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Non-sterile Liquid Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Non-sterile Liquid Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Non-sterile Liquid Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Non-sterile Liquid Price by Type (2019-2030) & (US$/Unit)
    Figure 21. Product Picture of Human Medication
    Figure 22. Product Picture of Nutraceuticals
    Figure 23. Product Picture of Cosmetics
    Figure 24. Product Picture of Medical Devices
    Figure 25. Global Non-sterile Liquid Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Non-sterile Liquid Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Non-sterile Liquid Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Non-sterile Liquid Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Non-sterile Liquid Price by Application (2019-2030) & (US$/Unit)
    Figure 30. North America Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Non-sterile Liquid Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Non-sterile Liquid Sales Volume (%), (2019-2030)
    Figure 42. United States Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030
    Figure 63. Non-sterile Liquid Industrial Chain
    Figure 64. Non-sterile Liquid Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Packaging of Effervescent Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-17Q10023
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pre-Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-8U10163
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Fast-disintegrating Tablets Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11I9951
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Immuno Oncology Assays Kit Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-34H832
Fri Dec 27 00:00:00 UTC 2024

Add to Cart